| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |